Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents
While Parkinson’s disease (PD) has a large and highly generalised therapeutic market, key opinion leaders (KOLs) interviewed by GlobalData have highlighted significant unmet needs within the field, including a lack of neuroprotective/disease-modifying …